肝細胞癌における開腹下ｍｉｃｒｏｗａｖｅ　ｃｏａｇｕｌａｔｉｏｎ　ｔｈｅｒａｐｙ（ＭＣＴ）の治療成績

概要

論文の詳細を見る
In our institute, laparotomic microwave coagulation therapy (MCT) is indicated for patients with hepatocellular carcinoma (HCC) and severe liver dysfunction, with HCC which is present in a difficult location to perform centesis percutaneously, and advanced HCC. Cumulative 1-, 3-, and 5-year survival rates in the laparotomic MCT therapy group were 87, 68, 39% respectively. Cumulative 1-, 3-, and 5-year tumor-free survival rates in the laparotomic MCT therapy group were 68, 42, 23% respectively. Although outcome of laparotomic MCT for HCC is entirely poorer than that of partial resection, the outcome of laparotomic MCT therapy is similar to that of partial resection therapy, limiting to the cases with severe liver dysfunction, severe cirrhotic liver, advanced HCC, recurrent HCC, and severe preoperative complication.Limiting to cases with advanced HCC, severe liver dysfunction, and serve preoperative complication, we believe that laparotomic MCT is the option of surgical treatment for HCC as well as partial resection.
特定非営利活動法人 Microwave Surgery研究会の論文